The global Lung Cancer Diagnostics market was valued at US$ 1883.5 million in 2023 and is anticipated to reach US$ 2783 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

Lung Cancer Diagnostics Market

Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostics.

Report Scope

The Lung Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Lung Cancer Diagnostics Market
Accounted market size in 2023	US$ 1883.5 million
Forecasted market size in 2030	US$ 2783 million
CAGR	5.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immunoassays Flow Cytometry Rapid Tests Molecular Assays Tissue Arrays Circulating Tumor Cells Pharmacodiagnostics Biomarkers Other
Segment by Application	Industrial Healthcare Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, BioMérieux, Qiagen, Advpharma, AIT Austrian Institute of Technology, Courtagen Life Sciences, DiagnoCure, BioMark Diagnostics, Mayo Clinic, HalioDx SAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Diagnostics Market growing?

Ans: The Lung Cancer Diagnostics Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the Lung Cancer Diagnostics Market size in 2030?

Ans: The Lung Cancer Diagnostics Market size in 2030 will be US$ 2783 million.

Who are the main players in the Lung Cancer Diagnostics Market report?

Ans: The main players in the Lung Cancer Diagnostics Market are Roche Diagnostics, BioMérieux, Qiagen, Advpharma, AIT Austrian Institute of Technology, Courtagen Life Sciences, DiagnoCure, BioMark Diagnostics, Mayo Clinic, HalioDx SAS

What are the Application segmentation covered in the Lung Cancer Diagnostics Market report?

Ans: The Applications covered in the Lung Cancer Diagnostics Market report are Industrial, Healthcare, Other

What are the Type segmentation covered in the Lung Cancer Diagnostics Market report?

Ans: The Types covered in the Lung Cancer Diagnostics Market report are Immunoassays, Flow Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating Tumor Cells, Pharmacodiagnostics, Biomarkers, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunoassays

1.2.3 Flow Cytometry

1.2.4 Rapid Tests

1.2.5 Molecular Assays

1.2.6 Tissue Arrays

1.2.7 Circulating Tumor Cells

1.2.8 Pharmacodiagnostics

1.2.9 Biomarkers

1.2.10 Other

1.3 Market by Application

1.3.1 Global Lung Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Industrial

1.3.3 Healthcare

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Diagnostics Market Perspective (2019-2030)

2.2 Lung Cancer Diagnostics Growth Trends by Region

2.2.1 Global Lung Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lung Cancer Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Lung Cancer Diagnostics Market Dynamics

2.3.1 Lung Cancer Diagnostics Industry Trends

2.3.2 Lung Cancer Diagnostics Market Drivers

2.3.3 Lung Cancer Diagnostics Market Challenges

2.3.4 Lung Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Diagnostics Players by Revenue

3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue

3.4 Global Lung Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2023

3.5 Lung Cancer Diagnostics Key Players Head office and Area Served

3.6 Key Players Lung Cancer Diagnostics Product Solution and Service

3.7 Date of Enter into Lung Cancer Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostics Breakdown Data by Type

4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

5 Lung Cancer Diagnostics Breakdown Data by Application

5.1 Global Lung Cancer Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lung Cancer Diagnostics Market Size (2019-2030)

6.2 North America Lung Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Lung Cancer Diagnostics Market Size by Country (2019-2024)

6.4 North America Lung Cancer Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Diagnostics Market Size (2019-2030)

7.2 Europe Lung Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Lung Cancer Diagnostics Market Size by Country (2019-2024)

7.4 Europe Lung Cancer Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Lung Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Diagnostics Market Size (2019-2030)

9.2 Latin America Lung Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Lung Cancer Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Lung Cancer Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Lung Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Detail

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction

11.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.1.5 Roche Diagnostics Recent Development

11.2 BioMérieux

11.2.1 BioMérieux Company Detail

11.2.2 BioMérieux Business Overview

11.2.3 BioMérieux Lung Cancer Diagnostics Introduction

11.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.2.5 BioMérieux Recent Development

11.3 Qiagen

11.3.1 Qiagen Company Detail

11.3.2 Qiagen Business Overview

11.3.3 Qiagen Lung Cancer Diagnostics Introduction

11.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.3.5 Qiagen Recent Development

11.4 Advpharma

11.4.1 Advpharma Company Detail

11.4.2 Advpharma Business Overview

11.4.3 Advpharma Lung Cancer Diagnostics Introduction

11.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.4.5 Advpharma Recent Development

11.5 AIT Austrian Institute of Technology

11.5.1 AIT Austrian Institute of Technology Company Detail

11.5.2 AIT Austrian Institute of Technology Business Overview

11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction

11.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.5.5 AIT Austrian Institute of Technology Recent Development

11.6 Courtagen Life Sciences

11.6.1 Courtagen Life Sciences Company Detail

11.6.2 Courtagen Life Sciences Business Overview

11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction

11.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.6.5 Courtagen Life Sciences Recent Development

11.7 DiagnoCure

11.7.1 DiagnoCure Company Detail

11.7.2 DiagnoCure Business Overview

11.7.3 DiagnoCure Lung Cancer Diagnostics Introduction

11.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.7.5 DiagnoCure Recent Development

11.8 BioMark Diagnostics

11.8.1 BioMark Diagnostics Company Detail

11.8.2 BioMark Diagnostics Business Overview

11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction

11.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.8.5 BioMark Diagnostics Recent Development

11.9 Mayo Clinic

11.9.1 Mayo Clinic Company Detail

11.9.2 Mayo Clinic Business Overview

11.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction

11.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.9.5 Mayo Clinic Recent Development

11.10 HalioDx SAS

11.10.1 HalioDx SAS Company Detail

11.10.2 HalioDx SAS Business Overview

11.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction

11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2019-2024)

11.10.5 HalioDx SAS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AIT Austrian Institute of Technology

Courtagen Life Sciences

List of Tables

Table 1. Global Lung Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunoassays

Table 3. Key Players of Flow Cytometry

Table 4. Key Players of Rapid Tests

Table 5. Key Players of Molecular Assays

Table 6. Key Players of Tissue Arrays

Table 7. Key Players of Circulating Tumor Cells

Table 8. Key Players of Pharmacodiagnostics

Table 9. Key Players of Biomarkers

Table 10. Key Players of Other

Table 11. Global Lung Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Lung Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Lung Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 14. Global Lung Cancer Diagnostics Market Share by Region (2019-2024)

Table 15. Global Lung Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 16. Global Lung Cancer Diagnostics Market Share by Region (2025-2030)

Table 17. Lung Cancer Diagnostics Market Trends

Table 18. Lung Cancer Diagnostics Market Drivers

Table 19. Lung Cancer Diagnostics Market Challenges

Table 20. Lung Cancer Diagnostics Market Restraints

Table 21. Global Lung Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 22. Global Lung Cancer Diagnostics Market Share by Players (2019-2024)

Table 23. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostics as of 2023)

Table 24. Ranking of Global Top Lung Cancer Diagnostics Companies by Revenue (US$ Million) in 2023

Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players Lung Cancer Diagnostics Product Solution and Service

Table 28. Date of Enter into Lung Cancer Diagnostics Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Lung Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 31. Global Lung Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 32. Global Lung Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 33. Global Lung Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 34. Global Lung Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 35. Global Lung Cancer Diagnostics Revenue Market Share by Application (2019-2024)

Table 36. Global Lung Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 37. Global Lung Cancer Diagnostics Revenue Market Share by Application (2025-2030)

Table 38. North America Lung Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Lung Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Lung Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Lung Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Europe Lung Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Europe Lung Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Asia-Pacific Lung Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 45. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 46. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 47. Latin America Lung Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Latin America Lung Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 49. Latin America Lung Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 50. Middle East & Africa Lung Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 51. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 52. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 53. Roche Diagnostics Company Detail

Table 54. Roche Diagnostics Business Overview

Table 55. Roche Diagnostics Lung Cancer Diagnostics Product

Table 56. Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 57. Roche Diagnostics Recent Development

Table 58. BioMérieux Company Detail

Table 59. BioMérieux Business Overview

Table 60. BioMérieux Lung Cancer Diagnostics Product

Table 61. BioMérieux Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 62. BioMérieux Recent Development

Table 63. Qiagen Company Detail

Table 64. Qiagen Business Overview

Table 65. Qiagen Lung Cancer Diagnostics Product

Table 66. Qiagen Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Qiagen Recent Development

Table 68. Advpharma Company Detail

Table 69. Advpharma Business Overview

Table 70. Advpharma Lung Cancer Diagnostics Product

Table 71. Advpharma Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Advpharma Recent Development

Table 73. AIT Austrian Institute of Technology Company Detail

Table 74. AIT Austrian Institute of Technology Business Overview

Table 75. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product

Table 76. AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 77. AIT Austrian Institute of Technology Recent Development

Table 78. Courtagen Life Sciences Company Detail

Table 79. Courtagen Life Sciences Business Overview

Table 80. Courtagen Life Sciences Lung Cancer Diagnostics Product

Table 81. Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Courtagen Life Sciences Recent Development

Table 83. DiagnoCure Company Detail

Table 84. DiagnoCure Business Overview

Table 85. DiagnoCure Lung Cancer Diagnostics Product

Table 86. DiagnoCure Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 87. DiagnoCure Recent Development

Table 88. BioMark Diagnostics Company Detail

Table 89. BioMark Diagnostics Business Overview

Table 90. BioMark Diagnostics Lung Cancer Diagnostics Product

Table 91. BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 92. BioMark Diagnostics Recent Development

Table 93. Mayo Clinic Company Detail

Table 94. Mayo Clinic Business Overview

Table 95. Mayo Clinic Lung Cancer Diagnostics Product

Table 96. Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Mayo Clinic Recent Development

Table 98. HalioDx SAS Company Detail

Table 99. HalioDx SAS Business Overview

Table 100. HalioDx SAS Lung Cancer Diagnostics Product

Table 101. HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 102. HalioDx SAS Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lung Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Lung Cancer Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Immunoassays Features

Figure 4. Flow Cytometry Features

Figure 5. Rapid Tests Features

Figure 6. Molecular Assays Features

Figure 7. Tissue Arrays Features

Figure 8. Circulating Tumor Cells Features

Figure 9. Pharmacodiagnostics Features

Figure 10. Biomarkers Features

Figure 11. Other Features

Figure 12. Global Lung Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Lung Cancer Diagnostics Market Share by Application: 2023 VS 2030

Figure 14. Industrial Case Studies

Figure 15. Healthcare Case Studies

Figure 16. Other Case Studies

Figure 17. Lung Cancer Diagnostics Report Years Considered

Figure 18. Global Lung Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Lung Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Lung Cancer Diagnostics Market Share by Region: 2023 VS 2030

Figure 21. Global Lung Cancer Diagnostics Market Share by Players in 2023

Figure 22. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostics as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2023

Figure 24. North America Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Lung Cancer Diagnostics Market Share by Country (2019-2030)

Figure 26. United States Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Lung Cancer Diagnostics Market Share by Country (2019-2030)

Figure 30. Germany Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Lung Cancer Diagnostics Market Share by Region (2019-2030)

Figure 38. China Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Lung Cancer Diagnostics Market Share by Country (2019-2030)

Figure 46. Mexico Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Lung Cancer Diagnostics Market Share by Country (2019-2030)

Figure 50. Turkey Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Lung Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Roche Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 53. BioMérieux Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 54. Qiagen Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 55. Advpharma Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 56. AIT Austrian Institute of Technology Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 57. Courtagen Life Sciences Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 58. DiagnoCure Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 59. BioMark Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 60. Mayo Clinic Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 61. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostics Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions